Prof. MUZAFFER METİNTAŞ Prof. MUZAFFER METİNTAŞ Personal Information Personal Information

(1)

Prof. MUZAFFER METİNTAŞ Prof. MUZAFFER METİNTAŞ Personal Information

Personal Information

F ax Pho ne:

F ax Pho ne: +90 0533 249 8191 Email:

Email: mmetintas@ogu.edu.tr Other Email:

Other Email: muzaffermetintas@gmail.com W eb:

W eb: https://avesis.ogu.edu.tr/mmetintas Internatio nal Researcher ID s

Internatio nal Researcher ID s ORCID: 0000-0002-4812-0170 Yoksis Researcher ID: 170965

Education Information Education Information

Expertise In Medicine, Anadolu University, School Of Medıcıne, Tıp Pr., Turkey 1987 - 1991 Undergraduate, Anadolu University, School Of Medıcıne, Tıp Pr., Turkey 1979 - 1986

Foreign Languages Foreign Languages

English, B2 Upper Intermediate

Research Areas Research Areas

Health Sciences

Academic Titles / Tasks Academic Titles / Tasks

Professor, Eskisehir Osmangazi University, Akciğer ve Plevra Kanserleri Uygulama ve Araştırma Merkezi, 2013 - Continues

Professor, Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bil. Bölüm, 1989 - Continues

Academic and Administrative Experience Academic and Administrative Experience

Rektörlüğe Bağlı Birim Başkanı, Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bil. Bölüm, 2021 - Continues Manager of Research and Application Center, Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bil. Bölüm, 2021 - Continues

Rectorate Commissioner, Eskisehir Osmangazi University, Rektörlük, Etik Çalışma İlkeleri ve İş Etiği Kurulu, 2019 - Continues

Manager of Research and Application Center, Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bil. Bölüm, 2015 - Continues

Eskisehir Osmangazi University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, 2000 - 2011 Eskisehir Osmangazi University, Rektörlük, 2008 - 2009

Jury Memberships

(2)

Jury Memberships Jury Memberships

Doctorate, Doctorate, University of Milan, December, 2020

Doctorate, Doctorate, Eskişehir Osmangazi Üniversitesi, November, 2020

Published journal articles indexed by SCI, SSCI, and AHCI Published journal articles indexed by SCI, SSCI, and AHCI

I. The ro le o f vo lumetric metho d in the assessment o f chemo therapy respo nse and predicting survivalThe ro le o f vo lumetric metho d in the assessment o f chemo therapy respo nse and predicting survival in malignant pleural meso thelio ma

in malignant pleural meso thelio ma

Urfali F., METİNTAŞ S., Gurgen A., Guntulu A., Ozkan R., METİNTAŞ M.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.17, no.1, pp.69-74, 2021 (Peer-Reviewed Journal) II. Predictio n o f Radiatio n Pneumo nitis W ith Machine L earning in Stage III L ung Cancer: A Pilo t Study.Predictio n o f Radiatio n Pneumo nitis W ith Machine L earning in Stage III L ung Cancer: A Pilo t Study.

Yakar M. Ç. , ETİZ D., METİNTAŞ M., AK G., Celik O.

Technology in cancer research & treatment, vol.20, 2021 (Peer-Reviewed Journal)

III. Hetero zygo us germline BL M mutatio ns increase susceptibility to asbesto s and meso thelio maHetero zygo us germline BL M mutatio ns increase susceptibility to asbesto s and meso thelio ma Bononi A., Goto K., AK G., Yoshikawa Y., Emi M., Pastorino S., Carparelli L., Ferro A., Nasu M., Kim J., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol.117, no.52, pp.33466-33473, 2020 (Peer-Reviewed Journal)

IV. The Clinical Impact o f Re-bio psies in L ung Adeno carcino ma: a Retro spective Multicenter StudyThe Clinical Impact o f Re-bio psies in L ung Adeno carcino ma: a Retro spective Multicenter Study Kabalak P. A. , Kizilgoz D., Kavurgaci S., DEMİRCİ N. Y. , YILMAZ Ş., AK G., METİNTAŞ S., METİNTAŞ M., Demirag F., Yilmaz U.

PATHOLOGY & ONCOLOGY RESEARCH, vol.26, no.4, pp.2703-2708, 2020 (Peer-Reviewed Journal) V. Po tential years o f life and pro ductivity lo ss due to malignant meso thelio ma in TurkeyPo tential years o f life and pro ductivity lo ss due to malignant meso thelio ma in Turkey

METİNTAŞ S., AK G., METİNTAŞ M.

ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH, 2020 (Peer-Reviewed Journal) VI. A review o f the co ho rts with enviro nmental and o ccupatio nal mineral fiber expo sureA review o f the co ho rts with enviro nmental and o ccupatio nal mineral fiber expo sure

METİNTAŞ S., AK G., METİNTAŞ M.

ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH, vol.74, pp.76-84, 2019 (Peer-Reviewed Journal) VII. Co mmo n Variants rs3815188 and rs1043994 o n No tch3 Gene Co nfer Susceptibility to L ung Cancer:Co mmo n Variants rs3815188 and rs1043994 o n No tch3 Gene Co nfer Susceptibility to L ung Cancer:

A Ho spital-Based Case-Co ntro l Study A Ho spital-Based Case-Co ntro l Study

Yağcı E., Değirmenci İ., Özbayer C., Ak G., Saydam F., Metintaş M.

JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, vol.38, no.1, pp.61-68, 2019 (Peer- Reviewed Journal)

VIII. W hat is the significance o f no n-specific pleuritis? A trick questio nW hat is the significance o f no n-specific pleuritis? A trick questio n Janssen J., Maldonado F., METİNTAŞ M.

CLINICAL RESPIRATORY JOURNAL, vol.12, no.9, pp.2407-2410, 2018 (Peer-Reviewed Journal)

IX. Macro sco pic co mplete resectio n is no t asso ciated with impro ved survival in patients with malignantMacro sco pic co mplete resectio n is no t asso ciated with impro ved survival in patients with malignant pleural meso thelio ma

pleural meso thelio ma

BATIREL H. F. , METİNTAŞ M., Caglar H. B. , AK G., Yumuk P. F. , Ahiskali R., BOZKURTLAR E., Bekiroglu N., LAÇİN T., YILDIZELİ B., et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.155, no.6, pp.2724-2732, 2018 (Peer-Reviewed Journal)

X. Turkey Natio nal Meso thelio ma Surveillance and Enviro nmental Asbesto s Expo sure Co ntro l Pro gramTurkey Natio nal Meso thelio ma Surveillance and Enviro nmental Asbesto s Expo sure Co ntro l Pro gram METİNTAŞ S., BATIREL H. F. , Bayram H., Yilmaz U., KARADAĞ M., AK G., METİNTAŞ M.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, vol.14, no.11, 2017 (Peer- Reviewed Journal)

XI. Midkine is a po tential no vel marker fo r malignant meso thelio ma with different pro gno stic andMidkine is a po tential no vel marker fo r malignant meso thelio ma with different pro gno stic and diagno stic values fro m meso thelin

diagno stic values fro m meso thelin

AK G., Tada Y., Shimada H., METİNTAŞ S., Ito M., Hiroshima K., Tagawa M., METİNTAŞ M.

BMC CANCER, vol.17, 2017 (Peer-Reviewed Journal)

XII. Asbesto s kno wledge and awareness level in central part o f Anato liaAsbesto s kno wledge and awareness level in central part o f Anato lia METİNTAŞ S., AK G., Bogar F., YILMAZ Ş., METİNTAŞ M.

(3)

INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, vol.23, no.3, pp.243-249, 2017 (Peer-Reviewed Journal)

XIII. D emo graphic, Clinical and Survival Characteristics o f L ung Cancer amo ng Elderly Patients in TurkeyD emo graphic, Clinical and Survival Characteristics o f L ung Cancer amo ng Elderly Patients in Turkey AK G., METİNTAŞ S., YILMAZ Ş., Bogar F., METİNTAŞ M.

JOURNAL OF THORACIC ONCOLOGY, vol.12, no.1, 2017 (Peer-Reviewed Journal)

XIV. F requency o f Mutatio ns and Related F acto rs in L ung Adeno carcino ma Cases in TurkeyF requency o f Mutatio ns and Related F acto rs in L ung Adeno carcino ma Cases in Turkey

YILMAZ Ş., KARADAĞ M., Demirci N., Kizilgoz D., Kabalak P. A. , METİNTAŞ M., AK G., Yilmaz U., Komurcuoglu B., AYDIN GÜÇLÜ Ö., et al.

XV. Pro gno stic Bio markers fo r Malignant Pleural Meso thelio ma Treated with Chemo therapyPro gno stic Bio markers fo r Malignant Pleural Meso thelio ma Treated with Chemo therapy Akgun H., METİNTAŞ S., AK G., Demirkol S., Aydin R., Isbilen M., Gure A., METİNTAŞ M.

XVI. Ado ptio n o f pleurecto my and deco rticatio n fo r malignant meso thelio ma leads to similar survival asAdo ptio n o f pleurecto my and deco rticatio n fo r malignant meso thelio ma leads to similar survival as extrapleural pneumo necto my

extrapleural pneumo necto my

BATIREL H. F. , METİNTAŞ M., Caglar H. B. , AK G., Yumuk P. F. , YILDIZELİ B., Yuksel M.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.151, no.2, pp.478-484, 2016 (Peer-Reviewed Journal)

XVII. D eterminatio n o f the Relatio nship Between rs4986790 and rs4986791 Variants o f TL R4 Gene andD eterminatio n o f the Relatio nship Between rs4986790 and rs4986791 Variants o f TL R4 Gene and L ung Cancer

L ung Cancer

KURT H., ÖZBAYER C., Bayramoglu A., Gunes H. V. , DEĞİRMENCİ İ., ÖNER K. S. , METİNTAŞ M.

INFLAMMATION, vol.39, no.1, pp.166-171, 2016 (Peer-Reviewed Journal)

XVIII. Image-Guided Pleural Bio psy: Issue o f the Expertise and Availability o f the Reso urces ReplyImage-Guided Pleural Bio psy: Issue o f the Expertise and Availability o f the Reso urces Reply METİNTAŞ M., YILDIRIM H., Kaya T., AK G., DÜNDAR E., Ozkan R., METİNTAŞ S.

RESPIRATION, vol.92, no.1, pp.57, 2016 (Peer-Reviewed Journal)

XIX. miRSNPs o f miR1274 and miR3202 Genes that Target MeCP2 and D NMT3b Are Asso ciated with L ungmiRSNPs o f miR1274 and miR3202 Genes that Target MeCP2 and D NMT3b Are Asso ciated with L ung Cancer Risk: A Study Co nducted o n MassARRAY Geno typing

Cancer Risk: A Study Co nducted o n MassARRAY Geno typing

ÖZBAYER C., DEĞİRMENCİ İ., AKYILDIZ ÜSTÜNER D., AK G., SAYDAM F., ÇOLAK E., Gunes H. V. , METİNTAŞ M.

JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, vol.35, no.3, pp.222-235, 2016 (Peer- Reviewed Journal)

XX. CT Scan-Guided Abrams' Needle Pleural Bio psy versus Ultraso und-Assisted Cutting Needle PleuralCT Scan-Guided Abrams' Needle Pleural Bio psy versus Ultraso und-Assisted Cutting Needle Pleural Bio psy fo r D iagno sis in Patients with Pleural Effusio n: A Rando mized, Co ntro lled Trial

Bio psy fo r D iagno sis in Patients with Pleural Effusio n: A Rando mized, Co ntro lled Trial Metintaş M., Yıldırım H., Kaya T., Ak G., Dündar E., Ozkan R., Metintaş S.

RESPIRATION, vol.91, no.2, pp.156-163, 2016 (Peer-Reviewed Journal)

XXI. The ro le o f NOD 1/CARD 4 and NOD 2/CARD 15 genetic variatio ns in lung cancer riskThe ro le o f NOD 1/CARD 4 and NOD 2/CARD 15 genetic variatio ns in lung cancer risk ÖZBAYER C., KURT H., Bayramoglu A., Gunes H. V. , METİNTAŞ M., DEĞİRMENCİ İ., ÖNER K. S.

INFLAMMATION RESEARCH, vol.64, no.10, pp.775-779, 2015 (Peer-Reviewed Journal)

XXII. Syndecan-1 alters heparan sulfate co mpo sitio n and signaling pathways in malignant meso thelio maSyndecan-1 alters heparan sulfate co mpo sitio n and signaling pathways in malignant meso thelio ma Heidari-Hamedani G., Vives R. R. , Seffouh A., Afratis N. A. , Oosterhof A., van Kuppevelt T. H. , Karamanos N. K. , METİNTAŞ M., Hjerpe A., Dobra K., et al.

CELLULAR SIGNALLING, vol.27, no.10, pp.2054-2067, 2015 (Peer-Reviewed Journal)

XXIII. The Relatio nship between the Co st o f Treatment and Pro gno sis in Malignant Meso thelio ma in TurkeyThe Relatio nship between the Co st o f Treatment and Pro gno sis in Malignant Meso thelio ma in Turkey The Relatio nship between the Co st o f Treatment and Pro gno sis in Malignant Meso thelio ma in Turkey The Relatio nship between the Co st o f Treatment and Pro gno sis in Malignant Meso thelio ma in Turkey AK G., METİNTAŞ S., KÖSE T., Bogar F., GİRGİNER N., BATIREL H. F. , UÇKUN N., METİNTAŞ M.

JOURNAL OF THORACIC ONCOLOGY, vol.10, no.9, 2015 (Peer-Reviewed Journal) XXIV. Asbesto s Kno wledge and Awareness L evelAsbesto s Kno wledge and Awareness L evel

METİNTAŞ S., AK G., Bogar F., METİNTAŞ M.

JOURNAL OF THORACIC ONCOLOGY, vol.10, no.9, 2015 (Peer-Reviewed Journal) XXV. Meso thelio ma Risk in TurkeyMeso thelio ma Risk in Turkey

METİNTAŞ M.

XXVI. The effectiveness and safety o f platinum-based pemetrexed and platinum-based gemcitabineThe effectiveness and safety o f platinum-based pemetrexed and platinum-based gemcitabine

(4)

treatment in patients with malignant pleural meso thelio ma treatment in patients with malignant pleural meso thelio ma AK G., METİNTAŞ S., Akarsu M., METİNTAŞ M.

BMC CANCER, vol.15, 2015 (Peer-Reviewed Journal)

XXVII. Micro RNA and mRNA F eatures o f Malignant Pleural Meso thelio ma and Benign Asbesto s-RelatedMicro RNA and mRNA F eatures o f Malignant Pleural Meso thelio ma and Benign Asbesto s-Related Pleural Effusio n

Pleural Effusio n

AK G., Tomaszek S. C. , Kosari F., METİNTAŞ M., Jett J. R. , METİNTAŞ S., YILDIRIM H., DÜNDAR E., Dong J., Aubry M.

C. , et al.

BIOMED RESEARCH INTERNATIONAL, vol.2015, 2015 (Peer-Reviewed Journal)

XXVIII. Plasmino gen Activato r Inhibito r-1 and Susceptibility to L ung Cancer: A Po pulatio n GeneticsPlasmino gen Activato r Inhibito r-1 and Susceptibility to L ung Cancer: A Po pulatio n Genetics Perspective

Perspective

Bayramoglu A., Gunes H. V. , METİNTAŞ M., DEĞİRMENCİ İ., GÜLER H. İ. , Ustuner C., MUSMUL A.

GENETIC TESTING AND MOLECULAR BIOMARKERS, vol.18, no.8, pp.587-590, 2014 (Peer-Reviewed Journal) XXIX. Pro teo me Screening o f Pleural Effusio ns Identifies Galectin 1 as a D iagno stic Bio marker andPro teo me Screening o f Pleural Effusio ns Identifies Galectin 1 as a D iagno stic Bio marker and

Highlights Several Pro gno stic Bio markers fo r Malignant Meso thelio ma Highlights Several Pro gno stic Bio markers fo r Malignant Meso thelio ma

Mundt F., Johansson H. J. , Forshed J., Arslan S., METİNTAŞ M., Dobra K., Lehtio J., Hjerpe A.

MOLECULAR & CELLULAR PROTEOMICS, vol.13, no.3, pp.701-715, 2014 (Peer-Reviewed Journal) XXX. D iagno stic and Pro gno stic Value o f So luble Syndecan-1 in Pleural MalignanciesD iagno stic and Pro gno stic Value o f So luble Syndecan-1 in Pleural Malignancies

Mundt F., Heidari-Hamedani G., Nilsonne G., METİNTAŞ M., Hjerpe A., Dobra K.

BIOMED RESEARCH INTERNATIONAL, vol.2014, 2014 (Peer-Reviewed Journal)

XXXI. THE EF F ECTIVENESS AND SAF ETY OF PL ATINUM BASED PEMETREXED AND PL ATINUM BASEDTHE EF F ECTIVENESS AND SAF ETY OF PL ATINUM BASED PEMETREXED AND PL ATINUM BASED GEMCITABINE TREATMENT IN THE PATIENTS W ITH MAL IGNANT PL EURAL MESOTHEL IOMA GEMCITABINE TREATMENT IN THE PATIENTS W ITH MAL IGNANT PL EURAL MESOTHEL IOMA AK G., METİNTAŞ S., Akarsu M., METİNTAŞ M.

JOURNAL OF THORACIC ONCOLOGY, vol.8, 2013 (Peer-Reviewed Journal)

XXXII. Hyaluro nan and N-ERC/Meso thelin as Key Bio markers in a Specific Two -Step Mo del to PredictHyaluro nan and N-ERC/Meso thelin as Key Bio markers in a Specific Two -Step Mo del to Predict Pleural Malignant Meso thelio ma

Pleural Malignant Meso thelio ma

Mundt F., Nilsonne G., Arslan S., Csuros K., Hillerdal G., YILDIRIM H., METİNTAŞ M., Dobra K., Hjerpe A.

PLOS ONE, vol.8, no.8, 2013 (Peer-Reviewed Journal)

XXXIII. Evaluatio n o f the renal resistive index and pulsatility index in patients with pleural effusio n byEvaluatio n o f the renal resistive index and pulsatility index in patients with pleural effusio n by duplex D o ppler ultraso no graphy.

duplex D o ppler ultraso no graphy.

Degirmenci N., METİNTAŞ M., Atlanoglu S., YILDIRIM H.

Japanese journal of radiology, vol.31, no.1, pp.39-44, 2013 (Peer-Reviewed Journal)

XXXIV. Efficacy and safety o f auto lo go us blo o d pleuro desis versus talc pleuro desis in patients withEfficacy and safety o f auto lo go us blo o d pleuro desis versus talc pleuro desis in patients with malignant pleural effusio ns: Preliminary results

malignant pleural effusio ns: Preliminary results Sari G., YILDIRIM H., AK G., METİNTAŞ M.

EUROPEAN RESPIRATORY JOURNAL, vol.40, 2012 (Peer-Reviewed Journal)

XXXV. Outco me o f patients diagno sed with fibrino us pleuritis after medical tho raco sco pyOutco me o f patients diagno sed with fibrino us pleuritis after medical tho raco sco py METİNTAŞ M., AK G., Cadirci O., YILDIRIM H., DÜNDAR E., METİNTAŞ S.

RESPIRATORY MEDICINE, vol.106, no.8, pp.1177-1183, 2012 (Peer-Reviewed Journal)

XXXVI. Ro le o f Real-Time Endo bro nchial Ultraso und-Guided Transbro nchial Needle Aspiratio n in theRo le o f Real-Time Endo bro nchial Ultraso und-Guided Transbro nchial Needle Aspiratio n in the D iagno sis and Mediastinal Staging o f L ung Cancer

D iagno sis and Mediastinal Staging o f L ung Cancer ALATAŞ F., DÜNDAR E., YILDIRIM H., METİNTAŞ M., AK G.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.32, no.2, pp.407-414, 2012 (Peer-Reviewed Journal) XXXVII. Enviro nmental asbesto s expo sure in rural Turkey and risk o f lung cancerEnviro nmental asbesto s expo sure in rural Turkey and risk o f lung cancer

METİNTAŞ S., METİNTAŞ M., AK G., Kalyoncu C.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH, vol.22, no.5, pp.468-479, 2012 (Peer- Reviewed Journal)

XXXVIII. D IF F ERENTIATION OF MAL IGNANT PL EURAL MESOTHEL IOMA F ROM BENIGN ASBESTOS-REL ATEDD IF F ERENTIATION OF MAL IGNANT PL EURAL MESOTHEL IOMA F ROM BENIGN ASBESTOS-REL ATED PL EURAL D ISEASE W ITH MICRORNA AND GENE EXPRESSION PROF IL ING

PL EURAL D ISEASE W ITH MICRORNA AND GENE EXPRESSION PROF IL ING

AK G., METİNTAŞ M., Tomaszek S., Jett J. R. , METİNTAŞ S., YILDIRIM H., DÜNDAR E., Aubry M. C. , Arslan S., Dong J., et al.

(5)

XXXIX. Medical Tho raco sco py vs CT Scan-Guided Abrams Pleural Needle Bio psy fo r D iagno sis o f PatientsMedical Tho raco sco py vs CT Scan-Guided Abrams Pleural Needle Bio psy fo r D iagno sis o f Patients W ith Pleural Effusio ns A Rando mized, Co ntro lled Trial

W ith Pleural Effusio ns A Rando mized, Co ntro lled Trial

METİNTAŞ M., AK G., DÜNDAR E., YILDIRIM H., Ozkan R., KURT E., Erginel S., ALATAŞ F., METİNTAŞ S.

CHEST, vol.137, no.6, pp.1362-1368, 2010 (Peer-Reviewed Journal)

XL. Endemic Malignant Meso thelio ma: Expo sure to Erio nite Is Mo re Impo rtant Than Genetic F acto rsEndemic Malignant Meso thelio ma: Expo sure to Erio nite Is Mo re Impo rtant Than Genetic F acto rs METİNTAŞ M., Hillerdal G., METİNTAŞ S., Dumortier P.

ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH, vol.65, no.2, pp.86-93, 2010 (Peer-Reviewed Journal) XLI. Three-dimensio nal evaluatio n o f chemo therapy respo nse in malignant pleural meso thelio maThree-dimensio nal evaluatio n o f chemo therapy respo nse in malignant pleural meso thelio ma

AK G., METİNTAŞ M., METİNTAŞ S., YILDIRIM H., Ozkan R., ÖZDEN H.

EUROPEAN JOURNAL OF RADIOLOGY, vol.74, no.1, pp.130-135, 2010 (Peer-Reviewed Journal)

XLII. Clinical Value o f F luo ro deo xygluco se-Po sitro n Emissio n To mo graphy/Co mputed To mo graphy inClinical Value o f F luo ro deo xygluco se-Po sitro n Emissio n To mo graphy/Co mputed To mo graphy in D ifferentiatio n o f Malignant Meso thelio ma fro m Asbesto s-Related Benign Pleural D isease An D ifferentiatio n o f Malignant Meso thelio ma fro m Asbesto s-Related Benign Pleural D isease An Observatio nal Pilo t Study

Observatio nal Pilo t Study

YILDIRIM H., METİNTAŞ M., ENTOK E., AK G., AK SİVRİKOZ İ., DÜNDAR E., Erginel S.

JOURNAL OF THORACIC ONCOLOGY, vol.4, no.12, pp.1480-1484, 2009 (Peer-Reviewed Journal)

XLIII. Pro gno stic F acto rs Acco rding to the Treatment Schedule in Malignant Pleural Meso thelio maPro gno stic F acto rs Acco rding to the Treatment Schedule in Malignant Pleural Meso thelio ma AK G., Metintas S., METİNTAŞ M., YILDIRIM H., Erginel S., KURT E., ALATAŞ F., Cadirci O.

JOURNAL OF THORACIC ONCOLOGY, vol.4, no.11, pp.1425-1430, 2009 (Peer-Reviewed Journal)

XLIV. The Asso ciatio n o f MMP-9 Enzyme Activity, MMP-9 C1562T Po lymo rphism, and MMP-2 and -9 andThe Asso ciatio n o f MMP-9 Enzyme Activity, MMP-9 C1562T Po lymo rphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 Gene Expressio n in L ung Cancer

TIMP-1, -2, -3, and -4 Gene Expressio n in L ung Cancer

Bayramoglu A., Gunes H. V. , METİNTAŞ M., DEĞİRMENCİ İ., MUTLU F., ALATAŞ F.

GENETIC TESTING AND MOLECULAR BIOMARKERS, vol.13, no.5, pp.671-678, 2009 (Peer-Reviewed Journal) XLV. Plasmino gen Activato r Inhibito r Type-1 Gene 4G/5G Po lymo rphism in Turkish Adult Patients withPlasmino gen Activato r Inhibito r Type-1 Gene 4G/5G Po lymo rphism in Turkish Adult Patients with

Asthma Asthma

TURGUT COŞAN D., KURT E., KURT H., DEĞİRMENCİ İ., Kucukarabaci B., METİNTAŞ M., Kucuk M. U. , Gunes H. V. , ÇOLAK E.

GENETIC TESTING AND MOLECULAR BIOMARKERS, vol.13, no.4, pp.543-546, 2009 (Peer-Reviewed Journal) XLVI. Irreversiblity o f Remo deled F eatures o n High-Reso lutio n Co mputerized To mo graphy Scans o fIrreversiblity o f Remo deled F eatures o n High-Reso lutio n Co mputerized To mo graphy Scans o f

Asthmatic Patients o n Co nventio nal Therapy: A 6-Year L o ngitudinal Study Asthmatic Patients o n Co nventio nal Therapy: A 6-Year L o ngitudinal Study KURT E., Ozkan R., Orman A., ÇALIŞIR C., METİNTAŞ M.

JOURNAL OF ASTHMA, vol.46, no.3, pp.300-307, 2009 (Peer-Reviewed Journal)

XLVII. Predicto rs o f talc pleuro desis o utco me in patients with malignant pleural effusio nsPredicto rs o f talc pleuro desis o utco me in patients with malignant pleural effusio ns YILDIRIM H., METİNTAŞ M., Ak G., METİNTAŞ S., Erginel S.

LUNG CANCER, vol.62, no.1, pp.139-144, 2008 (Peer-Reviewed Journal)

XLVIII. L o cal recurrence o f tumo r at sites o f interventio n in malignant pleural meso thelio maL o cal recurrence o f tumo r at sites o f interventio n in malignant pleural meso thelio ma

METİNTAŞ M., AK G., Parspour S., YILDIRIM H., Erginel S., ALATAŞ F., BATIREL H. F. , Sivrikoz C., METİNTAŞ S., DÜNDAR E.

LUNG CANCER, vol.61, no.2, pp.255-261, 2008 (Peer-Reviewed Journal) XLIX. Trimo dality treatment o f malignant pleural meso thelio maTrimo dality treatment o f malignant pleural meso thelio ma

BATIREL H. F. , METİNTAŞ M., Caglar H. B. , YILDIZELİ B., LAÇİN T., BOSTANCI K., Akgul A. G. , Evman S., Yuksel M.

JOURNAL OF THORACIC ONCOLOGY, vol.3, no.5, pp.499-504, 2008 (Peer-Reviewed Journal) L. Characteristics o f lung cancer patients with asbesto s-related radio lo gical findings.Characteristics o f lung cancer patients with asbesto s-related radio lo gical findings.

AK G., METİNTAŞ M., METİNTAŞ S., Erginel S., ALATAŞ F., YILDIRIM H., KURT E.

Tuberkuloz ve toraks, vol.56, no.3, pp.257-65, 2008 (Peer-Reviewed Journal)

LI. The significance and relatio nship between mast cells and tumo ur angio genesis in no n-small cell lungThe significance and relatio nship between mast cells and tumo ur angio genesis in no n-small cell lung carcino ma

carcino ma

Dundar E., Oner U., Peker B. C. , Metintas M., Isiksoy S., Ak G.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.36, no.1, pp.88-95, 2008 (Peer-Reviewed Journal) LII. Epidemio lo gy o f pleural meso thelio ma in a po pulatio n with no n-o ccupatio nal asbesto s expo sureEpidemio lo gy o f pleural meso thelio ma in a po pulatio n with no n-o ccupatio nal asbesto s expo sure

METİNTAŞ M., METİNTAŞ S., AK G., Erginel S., ALATAŞ F., KURT E., Ucgun I., YILDIRIM H.

RESPIROLOGY, vol.13, no.1, pp.117-121, 2008 (Peer-Reviewed Journal)

(6)

LIII. So ft tissue sarco ma metastatic to pleura.So ft tissue sarco ma metastatic to pleura.

YILDIRIM H., METİNTAŞ M., AK G., DÜNDAR E., Erginel S.

LIV. Oro pharyngeal candidiasis with dry-po wdered fluticaso ne pro pio nate: 500 mu g/day versus 200 muOro pharyngeal candidiasis with dry-po wdered fluticaso ne pro pio nate: 500 mu g/day versus 200 mu g/day

g/day

Kurt E., Yidirim H., Kiraz N., Orman A., Metintas M., Akgun Y., Erginel S.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA, vol.36, no.1, pp.17-20, 2008 (Peer-Reviewed Journal)

LV. Increased pleural fluid adeno sine deaminase levels in patients with malignant pleural effusio ns: AIncreased pleural fluid adeno sine deaminase levels in patients with malignant pleural effusio ns: A po tential predicto r o f talc pleuro desis o utco me

po tential predicto r o f talc pleuro desis o utco me

Yildirim H., Metintas M., Ak G., Erginel S., Alatas F., Kurt E., Metintas S., Ucgun I.

LUNG, vol.185, no.6, pp.349-354, 2007 (Peer-Reviewed Journal)

LVI. D etecting extratho racic metastases in patients with no n-small cell lung cancer: Is ro utine scanningD etecting extratho racic metastases in patients with no n-small cell lung cancer: Is ro utine scanning necessary?

necessary?

Metintas M., Ak G., Akcayir I. A. , Metintas S., Erginel S., Alatas F., Yildirim H., Kurt E., Ozkan R.

LVII. TC-99m MIBI spect imaging in patients with lung carcino ma: Is it a functio nal pro be o f multidrugTC-99m MIBI spect imaging in patients with lung carcino ma: Is it a functio nal pro be o f multidrug resistance genes?

resistance genes?

Ak I., Guelbas Z., Ocak S., Kaya E., Alatas F., Vardareli E., Metintas M.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, vol.31, no.5, pp.795-799, 2007 (Peer-Reviewed Journal) LVIII. L ung cancer in individuals less than 50 years o f ageL ung cancer in individuals less than 50 years o f age

Ak G., Metintas M., Metintas S., Yildirim H., Erginel S., Alatas F.

LUNG, vol.185, no.5, pp.279-286, 2007 (Peer-Reviewed Journal)

LIX. A retro spective analysis o f malignant pleural meso thelio ma patients treated either withA retro spective analysis o f malignant pleural meso thelio ma patients treated either with

chemo therapy o r best suppo rtive care between 1990 and 2005 - A single institutio n experience chemo therapy o r best suppo rtive care between 1990 and 2005 - A single institutio n experience Metintas M., Ak G., Erginel S., Alatas F., Yildirim H., Kurt E., Metintas S.

LX. Relatio nship between tumo rsize o f malignant pleural meso thelio ma and its respo nse toRelatio nship between tumo rsize o f malignant pleural meso thelio ma and its respo nse to chemo therapy

chemo therapy

Ozden H., Ak G., Metintas S., Metintas M., Sahin B., Erginel S., Civi K.

JOURNAL OF HEALTH SCIENCE, vol.53, no.1, pp.23-30, 2007 (Peer-Reviewed Journal)

LXI. Current treatment o ptio ns and bio lo gy o f perito neal meso thelio ma: meeting summary o f the firstCurrent treatment o ptio ns and bio lo gy o f perito neal meso thelio ma: meeting summary o f the first NIH perito neal meso thelio ma co nference

NIH perito neal meso thelio ma co nference

Hassan R., Alexander R., Antman K., Boffetta P., Churg A., Coit D., Hausner P., Kennedy R., Kindler H., Metintas M., et al.

ANNALS OF ONCOLOGY, vol.17, no.11, pp.1615-1619, 2006 (Peer-Reviewed Journal)

LXII. The evaluatio n o f lo cal disseminatio n o n interventio n sites in malignant meso thelio ma patients andThe evaluatio n o f lo cal disseminatio n o n interventio n sites in malignant meso thelio ma patients and indicatio ns fo r pro phylactic radio therapy

indicatio ns fo r pro phylactic radio therapy

Metintas M., Parspour S., Ak G., Yildirim H., Ergine S., Alatas F., Metintas S., Dundar E.

LUNG CANCER, vol.54, 2006 (Peer-Reviewed Journal) LXIII. Meso thelio ma in Turkey: A rural diseaseMeso thelio ma in Turkey: A rural disease

Metintas M.

LUNG CANCER, vol.54, 2006 (Peer-Reviewed Journal)

LXIV. Increased pleural fluid AD A level in patients with malignant meso thelio ma: A po tential predicto r fo rIncreased pleural fluid AD A level in patients with malignant meso thelio ma: A po tential predicto r fo r the o utco me o f talc pleuro desis

the o utco me o f talc pleuro desis

Yildirim H., Metintas M., Ak G., Erginel M. S. , Kurt E., Alatas F., Ucgun I.

LXV. Pleuro desis in fo llo w-up and treatment o f malignant pleural meso thelio ma patientsPleuro desis in fo llo w-up and treatment o f malignant pleural meso thelio ma patients Ak G., Metintas M., Yildirim H., Erginel S., Alatas F., Metintas S., Dundar E.

LXVI. Tri-mo dality treatment o f malignant pleural meso thelio ma in TurkeyTri-mo dality treatment o f malignant pleural meso thelio ma in Turkey

Batirel H. F. , Metintas M., Evman S., Lacin T., Akgul A. G. , Caglar H. B. , Yildizeli B., Yuksel M.

(7)

LXVII. Reco mbinant facto r VIIa treatment fo r life-threatening haemo ptysisReco mbinant facto r VIIa treatment fo r life-threatening haemo ptysis Yildirim H., Ucgun I., Yalcin A. U. , Gulbas Z., Sahin G., Acikalin M. F. , Metintas M., Ak G.

LXVIII. Predicto rs o f ho spital o utco me and intubatio n in COPD patients admitted to the respirato ry ICU fo rPredicto rs o f ho spital o utco me and intubatio n in COPD patients admitted to the respirato ry ICU fo r acute hypercapnic respirato ry failure

acute hypercapnic respirato ry failure

Ucgun I., Metintas M., Moral H., Alatas F., Yildirim H., Erginel S.

RESPIRATORY MEDICINE, vol.100, no.1, pp.66-74, 2006 (Peer-Reviewed Journal) LXIX. Peripheral intrapulmo nary lipo ma: a case repo rt and review o f the literature.Peripheral intrapulmo nary lipo ma: a case repo rt and review o f the literature.

Civi K., Ciftci E., Olgun E. G. , Erginel S., Ozkan R., METİNTAŞ M.

LXX. No nmalignant pleural lesio ns due to enviro nmental expo sure to asbesto s: a field-based, cro ss-No nmalignant pleural lesio ns due to enviro nmental expo sure to asbesto s: a field-based, cro ss- sectio nal study

sectio nal study

Metintas M., Metintas S., Hillerdal G., Ucgun I., Erginel S., Alatas F., Yildirim H.

EUROPEAN RESPIRATORY JOURNAL, vol.26, no.5, pp.875-880, 2005 (Peer-Reviewed Journal)

LXXI. Relatio nship between hypo xic hepatitis and co r pulmo nale in patients treated in the respirato ry ICU.Relatio nship between hypo xic hepatitis and co r pulmo nale in patients treated in the respirato ry ICU.

Ucgun I., Ozakyol A., Metintas M., Moral H., Orman A., Bal C., Yildirim H.

International journal of clinical practice, vol.59, no.11, pp.1295-300, 2005 (Peer-Reviewed Journal)

LXXII. High bo dy mass index and lo ng duratio n o f intubatio n increase po st-extubatio n strido r in patientsHigh bo dy mass index and lo ng duratio n o f intubatio n increase po st-extubatio n strido r in patients with mechanical ventilatio n

with mechanical ventilatio n

Erginel S., Ucgun I., Yildirim H., Metintas M., Parspour S.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, vol.207, no.2, pp.125-132, 2005 (Peer-Reviewed Journal) LXXIII. Vascular endo thelial gro wth facto r levels in pleural fluid and serum o f patients with tuberculo usVascular endo thelial gro wth facto r levels in pleural fluid and serum o f patients with tuberculo us

pleural effusio ns pleural effusio ns

Alatas F., Alatas O., Metintas M., Ozarslan A., Erginel S., Yildirim H.

CHEST, vol.128, no.1, pp.468-469, 2005 (Peer-Reviewed Journal) LXXIV. Vascular permeability in active pulmo nary tuberculo sisVascular permeability in active pulmo nary tuberculo sis

LXXV. Is measurement o f serum vascular endo thelial gro wth facto r reliable in patients with activeIs measurement o f serum vascular endo thelial gro wth facto r reliable in patients with active pulmo nary tuberculo sis? Respo nse

pulmo nary tuberculo sis? Respo nse

CHEST, vol.127, no.2, pp.686-687, 2005 (Peer-Reviewed Journal) LXXVI. Primary lympho epithelio ma-like carcino ma o f the lung.Primary lympho epithelio ma-like carcino ma o f the lung.

Bildirici K., AK G., Peker B., METİNTAŞ M., ALATAŞ F., Erginel S., Ucgun I.

LXXVII. High frequency o f D D po lymo rphism o f the angio tensin co nverting enzyme gene in TurkishHigh frequency o f D D po lymo rphism o f the angio tensin co nverting enzyme gene in Turkish asthmatic patients

asthmatic patients

Urhan M., DEĞİRMENCİ İ., Harmanci E., Gunes H., Metintas M., Basaran A.

ALLERGY AND ASTHMA PROCEEDINGS, vol.25, no.4, pp.243-247, 2004 (Peer-Reviewed Journal) LXXVIII. Vascular endo thelial gro wth facto r levels in active pulmo nary tuberculo sisVascular endo thelial gro wth facto r levels in active pulmo nary tuberculo sis

LXXIX. [Epidemio lo gical features o f bro nchial carcino ma cases with enviro nmental asbesto s expo sure].[Epidemio lo gical features o f bro nchial carcino ma cases with enviro nmental asbesto s expo sure].

Gürbüz B., METİNTAŞ S., METİNTAŞ M., Uçgun I., ALATAŞ F., Erginel S., Bektaş Y., Celik H., Harmanci E.

Tuberkuloz ve toraks, vol.52, no.1, pp.5-13, 2004 (Peer-Reviewed Journal) LXXX. [Synchro no us primary lung cancers: due to the fo ur cases].[Synchro no us primary lung cancers: due to the fo ur cases].

Uçgun I., Akçayir Sahin I., METİNTAŞ M., ALATAŞ F., Erginel S., DÜNDAR E.

Tuberkuloz ve toraks, vol.52, no.3, pp.262-7, 2004 (Peer-Reviewed Journal) LXXXI. Relapsing po lycho ndritisRelapsing po lycho ndritis

Alatas F., Ozkan R., Metintas M., Moral H., Erginel S., Ucgun I.

(8)

LXXXII. Acute phase reactants and cyto kine levels in unilateral co mmunity-acquired pneumo niaAcute phase reactants and cyto kine levels in unilateral co mmunity-acquired pneumo nia Kolsuz M., Erginel S., Alatas O., Alatas F., Metintas M., Ucgun I., Harmanci E., Colak O.

RESPIRATION, vol.70, no.6, pp.615-622, 2003 (Peer-Reviewed Journal) LXXXIII. [W egener granulo mato sis: three cases].[W egener granulo mato sis: three cases].

ALATAŞ F., METİNTAŞ M., Ozkan R., Erginel S., Uçgun I., YILDIRIM H.

Tuberkuloz ve toraks, vol.51, no.4, pp.440-5, 2003 (Peer-Reviewed Journal) LXXXIV. [Serum adeno sine deaminase activity in pulmo nary tuberculo sis].[Serum adeno sine deaminase activity in pulmo nary tuberculo sis].

ALATAŞ F., USLU S., Moral H., ALATAŞ İ. Ö. , METİNTAŞ M., Erginel S., Uçgun I.

Tuberkuloz ve toraks, vol.51, no.3, pp.277-81, 2003 (Peer-Reviewed Journal) LXXXV. [Pleural effusio n due to the o varian hyperstimulatio n syndro me].[Pleural effusio n due to the o varian hyperstimulatio n syndro me].

ALATAŞ F., Uçgun I., Moral H., Erginel S., Harmanci E., METİNTAŞ M.

LXXXVI. Malignant meso thelio ma due to enviro nmental expo sure to asbesto s - F o llo w-up o f a Turkish co ho rtMalignant meso thelio ma due to enviro nmental expo sure to asbesto s - F o llo w-up o f a Turkish co ho rt living in a rural area

living in a rural area

Metintas S., Metintas M., Ucgun I., Oner U.

LXXXVII. High-reso lutio n co mputed to mo graphy findings are co rrelated with disease severity in asthmaHigh-reso lutio n co mputed to mo graphy findings are co rrelated with disease severity in asthma Harmanci E., Kebapci M., Metintas M., Ozkan R.

LXXXVIII. Usefulness o f bo ne markers fo r detectio n o f bo ne metastases in lung cancer patientsUsefulness o f bo ne markers fo r detectio n o f bo ne metastases in lung cancer patients Alatas F., Alatas O., Metintas M., Colak O., Erginel S., Harmanci E.

CLINICAL BIOCHEMISTRY, vol.35, no.4, pp.293-296, 2002 (Peer-Reviewed Journal)

LXXXIX. Co mputed to mo graphy features in malignant pleural meso thelio ma and o ther co mmo nly seenCo mputed to mo graphy features in malignant pleural meso thelio ma and o ther co mmo nly seen pleural diseases

pleural diseases

Metintas M., Ucgun I., Elbek O., Erginel S., Metintas S., Kolsuz M., Harmanci E., Alatas F., Hillerdal G., Ozkan R., et al.

EUROPEAN JOURNAL OF RADIOLOGY, vol.41, no.1, pp.1-9, 2002 (Peer-Reviewed Journal)

XC. Pro gno stic facto rs in diffuse malignant pleural meso thelio ma: effects o f pretreatment clinical andPro gno stic facto rs in diffuse malignant pleural meso thelio ma: effects o f pretreatment clinical and labo rato ry characteristics

labo rato ry characteristics

Metintas M., Metintas S., Ucgun I., Gibbs A., Harmanci E., Alatas F., Erginel S., Tel N., Pasaoglu O.

XCI. p53, p21 and metallo thio nein immuno reactivities in patients with malignant pleural meso thelio ma:p53, p21 and metallo thio nein immuno reactivities in patients with malignant pleural meso thelio ma:

co rrelatio ns with the epidemio lo gical features and pro gno sis o f meso thelio mas with enviro nmental co rrelatio ns with the epidemio lo gical features and pro gno sis o f meso thelio mas with enviro nmental asbesto s expo sure

asbesto s expo sure

Isik R., Metintas M., Gibbs A., Metintas S., Jasani B., Oner U., Harmanci E., Demircan S., Isiksoy S.

RESPIRATORY MEDICINE, vol.95, no.7, pp.588-593, 2001 (Peer-Reviewed Journal) XCII. Antipho spho lipid syndro me asso ciated with intestinal amo ebiasisAntipho spho lipid syndro me asso ciated with intestinal amo ebiasis

Korkmaz C., Harmanci E., Metintas M., Gulbas Z.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, vol.33, no.12, pp.938-940, 2001 (Peer-Reviewed Journal) XCIII. D iagno stic value o f CEA, CA 15-3, CA 19-9, CYF RA 21-1, NSE and TSA assay in pleural effusio nsD iagno stic value o f CEA, CA 15-3, CA 19-9, CYF RA 21-1, NSE and TSA assay in pleural effusio ns

Alatas F., Alatas O., Metintas M., Colak O., Harmanci E., Demir S.

XCIV. The prevalence o f asthma and allergy amo ng university freshmen in Eskisehir, TurkeyThe prevalence o f asthma and allergy amo ng university freshmen in Eskisehir, Turkey Ozdemir N., Ucgun I., Metintas S., Kolsuz M., Metintas M.

XCV. L o w prevalence o f allergy to co ckro ach and latex in asthmatic patients in Eskisehir (Anato lia),L o w prevalence o f allergy to co ckro ach and latex in asthmatic patients in Eskisehir (Anato lia), Turkey

Turkey

Harmanci E., Metintas M., Alatas F., Erginel S., Mutlu S.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, vol.10, no.3, pp.162-165, 2000 (Peer- Reviewed Journal)

XCVI. Cisplatin, mito mycin, and interfero n-alpha 2a co mbinatio n chemo immuno therapy in the treatment o fCisplatin, mito mycin, and interfero n-alpha 2a co mbinatio n chemo immuno therapy in the treatment o f

(9)

diffuse malignant pleural meso thelio ma diffuse malignant pleural meso thelio ma

Metintas M., Ozdemir N., Ucgun I., Elbek O., Kolsuz M., Mutlu S., Metintas S.

XCVII. Enviro nmental asbesto s expo sure and malignant pleural meso thelio maEnviro nmental asbesto s expo sure and malignant pleural meso thelio ma

Metintas M., Ozdemir N., Hillerdal G., Ucgun I., Metintas S., Baykul C., Elbek O., Mutlu S., Kolsuz M.

XCVIII. Malignant meso thelio ma due to enviro nmental expo sure to erio nite: fo llo w-up o f a Turkish emigrantMalignant meso thelio ma due to enviro nmental expo sure to erio nite: fo llo w-up o f a Turkish emigrant co ho rt

co ho rt

Metintas M., Hillerdal G., Metintas S.

EUROPEAN RESPIRATORY JOURNAL, vol.13, no.3, pp.523-526, 1999 (Peer-Reviewed Journal) XCIX. An unusual case o f eso phageal tuberculo sis in an adultAn unusual case o f eso phageal tuberculo sis in an adult

Alatas F., Ozdemir N., Isiksoy S., Metintas M., Erginel S., Harmanci E., Mutlu S.

C. Prevalence o f o ccupatio nal asthma amo ng auto mo bile and furniture painters in the center o fPrevalence o f o ccupatio nal asthma amo ng auto mo bile and furniture painters in the center o f Eskisehir (Turkey): the effects o f ato py and smo king habits o n o ccupatio nal asthma

Eskisehir (Turkey): the effects o f ato py and smo king habits o n o ccupatio nal asthma Ucgun I., Ozdemir N., Metintas M., Metintas S., Erginel S., Kolsuz M.

ALLERGY, vol.53, no.11, pp.1096-1100, 1998 (Peer-Reviewed Journal) CI. Smo king patterns o f university students in Eskisehir, TurkeySmo king patterns o f university students in Eskisehir, Turkey

Metintas S., Sariboyaci M., Nuhoglu S., Metintas M., Kalyoncu C., Etiz S., Ozdemir N., Aktas C.

PUBLIC HEALTH, vol.112, no.4, pp.261-264, 1998 (Peer-Reviewed Journal)

CII. The value o f tumo r marker determinatio n in bro nchial washing o f lung cancer patients.The value o f tumo r marker determinatio n in bro nchial washing o f lung cancer patients.

Alatas O., Colak O., Alatas F., Metintas M., Uslu S., Ozdemir N.

CLINICAL CHEMISTRY, vol.44, 1998 (Peer-Reviewed Journal)

CIII. Co mparative analysis o f bio chemical parameters fo r differentiatio n o f pleural exudates fro mCo mparative analysis o f bio chemical parameters fo r differentiatio n o f pleural exudates fro m transudates L ight's criteria, cho lestero l, bilirubin, albumin gradient, alkaline pho sphatase, creatine transudates L ight's criteria, cho lestero l, bilirubin, albumin gradient, alkaline pho sphatase, creatine kinase, and uric acid

kinase, and uric acid

Metintas M., Alatas O., Alatas F., Colak O., Ozdemir N., Erginel S.

CLINICA CHIMICA ACTA, vol.264, no.2, pp.149-162, 1997 (Peer-Reviewed Journal)

CIV. Malignant lo calized fibro us tumo r o f the pleura o ccurring in a perso n enviro nmentally expo sed toMalignant lo calized fibro us tumo r o f the pleura o ccurring in a perso n enviro nmentally expo sed to tremo lite asbesto s

tremo lite asbesto s

Metintas M., Gibbs A., Harmanci E., Ozdemir N., Pasaoglu O., Isiksoy S., Arslan R., Erginel S., Adapinar B.

CV. The effect o f smo king o n antio xidant levels in bro ncho alveo lar lavage fluidThe effect o f smo king o n antio xidant levels in bro ncho alveo lar lavage fluid ALATAŞ F., Ergínel S., Özdemír N., ALATAŞ İ. Ö. , METİNTAŞ M., Işik R.

Chest, vol.110, 1996 (Peer-Reviewed Journal)

CVI. CT-GUID ED PL EURAL NEED L E-BIOPSY IN THE D IAGNOSIS OF MAL IGNANT MESOTHEL IOMACT-GUID ED PL EURAL NEED L E-BIOPSY IN THE D IAGNOSIS OF MAL IGNANT MESOTHEL IOMA

METINTAS M., OZDEMIR N., ISIKSOY S., KAYA T., EKICI M., ERGINEL S., HARMANCI E., ERDINC P., ULGEY N., ALATAS F.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, vol.19, no.3, pp.370-374, 1995 (Peer-Reviewed Journal) CVII. Chro mo so me analysis in pleural effusio ns. Efficiency o f this metho d in the differential diagno sis o fChro mo so me analysis in pleural effusio ns. Efficiency o f this metho d in the differential diagno sis o f

pleural effusio ns.

METINTAS M., OZDEMIR N., SOLAK M., ARTAN S., OZDEMIR M., BASARAN N., EKICI M., ERGINEL S.

Respiration; international review of thoracic diseases, vol.61, no.6, pp.330-5, 1994 (Peer-Reviewed Journal) CVIII. THE EF F ICACY AND SAF ETY OF OND ANSETRON AND METOCL OPRAMID E COMBINED W ITHTHE EF F ICACY AND SAF ETY OF OND ANSETRON AND METOCL OPRAMID E COMBINED W ITH

D EXAMETHASONE F OR PREVENTION OF MUL TI-D AY CISPL ATIN THERAPY IN THE PATIENTS W ITH D EXAMETHASONE F OR PREVENTION OF MUL TI-D AY CISPL ATIN THERAPY IN THE PATIENTS W ITH PUL MONARY NEOPL ASM

PUL MONARY NEOPL ASM

OZDEMIR N., METINTAS M., EKICI M., YILDIZ F., ERGINEL S., OLGEY N., INAN P., HARMANCI E., ALATAS F.

AMERICAN REVIEW OF RESPIRATORY DISEASE, vol.147, no.4, 1993 (Peer-Reviewed Journal) CIX. CHROMOSOME ANAL YSES OF PL EURAL EF F USIONSCHROMOSOME ANAL YSES OF PL EURAL EF F USIONS

SOLAK M., OZDEMIR N., METINTAS M., OZDEMIR M., BASARAN N., TUNA M.

AMERICAN JOURNAL OF HUMAN GENETICS, vol.49, no.4, pp.250, 1991 (Peer-Reviewed Journal)

(10)

Articles Published in Other Journals Articles Published in Other Journals

I. Efficacy and safety o f auto lo go us blo o d pleuro desis versus talc pleuro desis in sympto matic pleuralEfficacy and safety o f auto lo go us blo o d pleuro desis versus talc pleuro desis in sympto matic pleural effusio ns: A rando mized trial

effusio ns: A rando mized trial

METİNTAŞ M., YILDIRIM H., Guntulu A. K. , Sari G., METİNTAŞ S.

EURASIAN JOURNAL OF PULMONOLOGY, vol.23, no.1, pp.25-31, 2021 (Peer-Reviewed Journal) II. Evaluatio n o f parao xo nase-1 enzyme activity and o xidative stress relatio ns in malignantEvaluatio n o f parao xo nase-1 enzyme activity and o xidative stress relatio ns in malignant

meso thelio ma cases meso thelio ma cases

Turgut Coşan D., Ak G., Colak E., Dal A., Öner Ç., Soyocak A., Çolak E., Güneş H. V. , Metintaş M.

Eurasian Journal of Pulmonology, vol.22, no.3, pp.153-157, 2020 (Peer-Reviewed Journal) III. L ung Stereo tactic Bo dy Radio therapy: Single-Center ExperienceL ung Stereo tactic Bo dy Radio therapy: Single-Center Experience

Akçay M. Ç. , Etiz D., Metintaş M., Ak G., Özen A., Yılmaz Ş.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.35, no.3, pp.274-282, 2020 (Peer-Reviewed Journal)

IV. Pro spective Study o f the Utility o f Co mputed To mo graphy Triage o f Pleural Bio psy Strategies inPro spective Study o f the Utility o f Co mputed To mo graphy Triage o f Pleural Bio psy Strategies in Patients W ith Pleural D iseases

Patients W ith Pleural D iseases

METİNTAŞ M., AK G., METİNTAŞ S., Yildirim H., DÜNDAR E., Rahman N.

JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, vol.26, no.3, pp.210-218, 2019 (Peer-Reviewed Journal)

V. The relatio nship between treatment co st and pro gno sis o f malignant pleural meso thelio ma in TurkeyThe relatio nship between treatment co st and pro gno sis o f malignant pleural meso thelio ma in Turkey Guntulu A. K. , METİNTAŞ S., KÖSE T., Bogar F., GİRGİNER N., BATIREL H. F. , UÇKUN N., METİNTAŞ M.

EURASIAN JOURNAL OF PULMONOLOGY, vol.21, no.1, pp.50-56, 2019 (Peer-Reviewed Journal)

VI. Predicting Malignant Meso thelio ma by Analyzing Serum N-ERC/Meso thelin, C-ERC/Meso thelin,Predicting Malignant Meso thelio ma by Analyzing Serum N-ERC/Meso thelin, C-ERC/Meso thelin, Hyaluro nan, Osteo po ntin, and Syndecan-1 L evels

Hyaluro nan, Osteo po ntin, and Syndecan-1 L evels

Arslan S., Mundt F., METİNTAŞ S., AK G., Dobra K., Hjerpe A., METİNTAŞ M.

VII. Validity and Reliability o f Asbesto s Kno wledge and Awareness Questio nnaire fo r Enviro nmentalValidity and Reliability o f Asbesto s Kno wledge and Awareness Questio nnaire fo r Enviro nmental Asbesto s Expo sure in Rural Areas

Asbesto s Expo sure in Rural Areas

METİNTAŞ S., AK G., YILMAZ Ş., Bogar F., METİNTAŞ M.

EURASIAN JOURNAL OF PULMONOLOGY, vol.19, no.1, pp.34-40, 2017 (Peer-Reviewed Journal) VIII. Erlo tinib Treatment in a Case o f L ung Adeno carcino ma Mimicking Interstitial L ung D iseaseErlo tinib Treatment in a Case o f L ung Adeno carcino ma Mimicking Interstitial L ung D isease

YILMAZ Ş., AK G., METİNTAŞ M.

IX. EXPRESSION AND POTENTIAL ROL E OF miR200b AND miR1274a IN L UNG CANCER PATIENTSEXPRESSION AND POTENTIAL ROL E OF miR200b AND miR1274a IN L UNG CANCER PATIENTS ÖZBAYER C., AK G., AKYILDIZ ÜSTÜNER D., SAYDAM F., Gunes H. V. , METİNTAŞ M.

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, vol.8, pp.137-140, 2017 (Peer-Reviewed Journal) X. Akciğer Kanserli Hastalarda Plazma D NA Metiltransferaz ve Metil-CpG ’ye Bağlanan Pro teinAkciğer Kanserli Hastalarda Plazma D NA Metiltransferaz ve Metil-CpG ’ye Bağlanan Pro tein

Seviyelerinin D eğerlendirilmesi Seviyelerinin D eğerlendirilmesi

ÖZBAYER C., ÜSTÜNER D., AK G., SAYDAM F., METİNTAŞ M., DEĞİRMENCİ İ.

Dicle Tıp Dergisi, vol.44, no.1, pp.57-64, 2017 (Peer-Reviewed Journal)

XI. Yaşlı akciğer kanserli hastaların epidemiyo lo jik, klinik ve sağ kalım ö zellikleriYaşlı akciğer kanserli hastaların epidemiyo lo jik, klinik ve sağ kalım ö zellikleri AK G., METİNTAŞ S., YILMAZ Ş., BOĞAR F., METİNTAŞ M.

İzmir Göğüs Hastanesi Dergisi, 2017 (Peer-Reviewed Journal)

XII. Akciğer L ezyo nu Olan Hastaların Aspirasyo nsuz İnce İğne Sito lo jisi ile Tanısı: 10 Vaka Rapo ru ileAkciğer L ezyo nu Olan Hastaların Aspirasyo nsuz İnce İğne Sito lo jisi ile Tanısı: 10 Vaka Rapo ru ile L iteratür / D eğerlendirmesi D iagno sis o f Patients with L ung L esio ns By F ine Needle No naspiratio n L iteratür / D eğerlendirmesi D iagno sis o f Patients with L ung L esio ns By F ine Needle No naspiratio n Cyto lo gy: Ten Cases Repo rts And Review o f The L iterature

Cyto lo gy: Ten Cases Repo rts And Review o f The L iterature YILMAZ Ş., AK G., DÜNDAR E., METİNTAŞ M.

OSMANGAZİ JOURNAL OF MEDICINE, vol.39, no.1, pp.36, 2017 (Peer-Reviewed Journal) XIII. Asbest temasının akciğer kanserinin kliniğine yansımasıAsbest temasının akciğer kanserinin kliniğine yansıması

AK G., METİNTAŞ S., YILMAZ Ş., METİNTAŞ M.

İzmir Göğüs Hastanesi Dergisi, 2017 (Peer-Reviewed Journal)

(11)

XIV. D rug carrier nano systems in malignant pleural meso thelio maD rug carrier nano systems in malignant pleural meso thelio ma

TURGUT COŞAN D., AK G., DAĞ İ., Soyocak A., DİKMEN G., Dal A., Gunes H. V. , METİNTAŞ M.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.64, no.1, pp.60-68, 2016 (Peer-Reviewed Journal) XV. Turkish Clinical Guideline fo r Malignant Pleural Meso thelio maTurkish Clinical Guideline fo r Malignant Pleural Meso thelio ma

Metintas M.

EURASIAN JOURNAL OF PULMONOLOGY, vol.17, pp.1-21, 2015 (Peer-Reviewed Journal) XVI. Turkey Asbesto s Co ntro l Strategic Plan F inal Repo rtTurkey Asbesto s Co ntro l Strategic Plan F inal Repo rt

METİNTAŞ M., BATIREL H. F.

TURKISH THORACIC JOURNAL, vol.16, no.2, pp.1-26, 2015 (Peer-Reviewed Journal) XVII. Malign Plevral Mezo telyo ma Türkiye Standartlar RehberiMalign Plevral Mezo telyo ma Türkiye Standartlar Rehberi

METİNTAŞ M., BATIREL H. F. , ZAMANİ A., YILMAZ DEMİRCİ N., ATİLLA S., KARA V., AK G.

Eurasian Journal of pulmonology, vol.17, pp.1-21, 2015 (Peer-Reviewed Journal) XVIII. Medical Tho raco sco py at 105. AnniversaryMedical Tho raco sco py at 105. Anniversary

METİNTAŞ M.

EURASIAN JOURNAL OF PULMONOLOGY, vol.17, no.3, pp.129-135, 2015 (Peer-Reviewed Journal) XIX. D NA Metiltransferaz 3b ve Metil Bağlayan Bö lge Pro teini 1 i Hedefleyen Mirna GenD NA Metiltransferaz 3b ve Metil Bağlayan Bö lge Pro teini 1 i Hedefleyen Mirna Gen

Po limo rfizmlerinin Akciğer Kanseri İle İlişkisinin Belirlenmesi Po limo rfizmlerinin Akciğer Kanseri İle İlişkisinin Belirlenmesi

ÖZBAYER C., DEĞİRMENCİ İ., ÜSTÜNER D., AK G., SAYDAM F., ÇOLAK E., GÜNEŞ H. V. , METİNTAŞ M.

OSMANGAZİ TIP DERGİSİ, vol.36, no.2, pp.16-26, 2014 (Peer-Reviewed Journal)

XX. D NA Metiltransfreaz-3b ve Metil Bağlayan Bö lge Pro teini-1’i Hedefleyen miRNA GenD NA Metiltransfreaz-3b ve Metil Bağlayan Bö lge Pro teini-1’i Hedefleyen miRNA Gen Po limo rfizmlerinin Akciğer Kanseri ile İlişkisinin Belirlenmesi

Po limo rfizmlerinin Akciğer Kanseri ile İlişkisinin Belirlenmesi

Osmangazi Tıp Dergisi, vol.36, no.2, pp.16-26, 2014 (Peer-Reviewed Journal)

XXI. D NA Metiltransferaz 3b ve metil bağlayan bö lge pro teini 1 I hedefleyen miRNA genD NA Metiltransferaz 3b ve metil bağlayan bö lge pro teini 1 I hedefleyen miRNA gen po limo rfizmlerinin akciğer kanseri ile ilişkisinin belirlenmesi

po limo rfizmlerinin akciğer kanseri ile ilişkisinin belirlenmesi

Osmangazi Tıp Dergisi, 2014 (Peer-Reviewed Journal)

XXII. The Safety o f Medical Tho raco sco py in a Gro up at High Risk fo r Co mplicatio nsThe Safety o f Medical Tho raco sco py in a Gro up at High Risk fo r Co mplicatio ns METİNTAŞ M., AK G., YILDIRIM H., Danacioglu S., DÜNDAR E., METİNTAŞ S.

JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, vol.20, no.3, pp.224-231, 2013 (Peer-Reviewed Journal)

XXIII. Malignant pericardial meso thelio ma fo llo wing tho racal radio therapy Malignant pericardial meso thelio ma fo llo wing tho racal radio therapy disseminatio n fro mdisseminatio n fro m pericardium to pleura

pericardium to pleura

YILDIRIM H., METİNTAŞ M., AK G.

Tüberküloz ve Toraks Dergisi, 2010 (Peer-Reviewed Journal)

XXIV. The efficacy o f no n-invasive po sitive pressure ventilatio n in ARD S: a co ntro lled co ho rt studyThe efficacy o f no n-invasive po sitive pressure ventilatio n in ARD S: a co ntro lled co ho rt study Ucgun I., YILDIRIM H., METİNTAŞ M., AK G.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.58, no.1, pp.16-24, 2010 (Peer-Reviewed Journal) XXV. Malignant pericardial meso thelio ma fo llo wing tho racal radio therapy; disseminatio n fro mMalignant pericardial meso thelio ma fo llo wing tho racal radio therapy; disseminatio n fro m

pericardium to pleura pericardium to pleura

YILDIRIM H., METİNTAŞ M., Guntulu A. K.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.58, no.3, pp.301-305, 2010 (Peer-Reviewed Journal) XXVI. Characteristics o f L ung Adeno carcino ma Cases Acco rding to Smo king Histo ryCharacteristics o f L ung Adeno carcino ma Cases Acco rding to Smo king Histo ry

AK G., METİNTAŞ M., YILDIRIM H., METİNTAŞ S., Erginel S., ALATAŞ F.

TURKISH THORACIC JOURNAL, vol.10, no.2, pp.69-74, 2009 (Peer-Reviewed Journal) XXVII. Akciğer adeno karsino mlu o lguların sigara ö yküsüne go re ö zellikleriAkciğer adeno karsino mlu o lguların sigara ö yküsüne go re ö zellikleri

AK G., METİNTAŞ M., YILDIRIM H., METİNTAŞ S., ERGİNEL M. S. , ALATAŞ F.

Türk Toraks Dergisi, 2009 (Peer-Reviewed Journal)

XXVIII. Pleuro desis in fo llo w up and treatment o f malignant pleural meso thelio ma patientsPleuro desis in fo llo w up and treatment o f malignant pleural meso thelio ma patients AK G., METİNTAŞ M., YILDIRIM H., METİNTAŞ S., DÜNDAR E., ERGİNEL M. S.

Tüberküloz ve Toraks Dergisi, 2009 (Peer-Reviewed Journal)

(12)

XXIX. Mide metastazlı akciğer kanseri o lgusuMide metastazlı akciğer kanseri o lgusu AK G., YILDIRIM H., SERPİL D., METİNTAŞ M.

XXX. Parapnö mo nik efüzyo n ve ampiyemli hastaların ö zellikleriParapnö mo nik efüzyo n ve ampiyemli hastaların ö zellikleri

AK G., SERPİL D., YILDIRIM H., ERGİNEL M. S. , ALATAŞ F., DÖNER E., METİNTAŞ M.

Solunum Hastalıkları, 2008 (Peer-Reviewed Journal) XXXI. Pleural metastasis fro m so ft tissue sarco maPleural metastasis fro m so ft tissue sarco ma

METİNTAŞ M., AK G., DÜNDAR E., Erginel S.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.56, no.4, pp.486, 2008 (Peer-Reviewed Journal) XXXII. Yaşlılarda küçük hücreli akciğer kanseriYaşlılarda küçük hücreli akciğer kanseri

YILDIRIM H., METİNTAŞ M., AK G., ERGİNEL M. S. , METİNTAŞ S., KURT E., ALATAŞ F., UÇGUN İ., ŞAHİN İ.

Toraks Dergisi, vol.9, pp.7-12, 2008 (Peer-Reviewed Journal) XXXIII. Small Cell L ung Cancer in Elderly PatientsSmall Cell L ung Cancer in Elderly Patients

YILDIRIM H., METİNTAŞ M., AK G., Erginel S., METİNTAŞ S., KURT E., ALATAŞ F., Ucgun I., Sahin I. A.

TURKISH THORACIC JOURNAL, vol.9, no.1, pp.7-12, 2008 (Peer-Reviewed Journal) XXXIV. F ro m the autho rsF ro m the autho rs

YILDIRIM H., METİNTAŞ M., Guntulu A. K. , DÜNDAR E., Erginel S.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.56, no.4, pp.488, 2008 (Peer-Reviewed Journal) XXXV. Akciğer kanserli hastalarda uzak metastaz dağılımı Akciğer kanserli hastalarda uzak metastaz dağılımı klinik ö zellikleri ve uzak metastazların tayiniklinik ö zellikleri ve uzak metastazların tayini

İLKNUR A. Ş. , AK G., METİNTAŞ M., ERGİNEL M. S. , KURT E., ALATAŞ F., UÇGUN İ., YILDIRIM H., METİNTAŞ S.

Osmangazi Tıp dergisi, 2007 (Peer-Reviewed Journal)

XXXVI. Akciğer kanserli o lguların tanı aşamasındaki evrelerini etkileyen epidemiyo lo jik Akciğer kanserli o lguların tanı aşamasındaki evrelerini etkileyen epidemiyo lo jik klinik ve radyo lo jikklinik ve radyo lo jik ö zellikler

ö zellikler

AK G., METİNTAŞ M., METİNTAŞ S., ERGİNEL M. S. , KURT E., ALATAŞ F., UÇGUN İ., YILDIRIM H.

Osmangazi Tıp Dergisi, 2006 (Peer-Reviewed Journal) XXXVII. Talc pleuro desis Talc pleuro desis Systemic Inflammato ry Respo nseSystemic Inflammato ry Respo nse

YILDIRIM H., METİNTAŞ M., UÇGUN İ., ERGİNEL M. S. , ALATAŞ F., KURT E., METİNTAŞ S., AK G.

Turkish Respiratory Journal, 2006 (Peer-Reviewed Journal)

XXXVIII. 1995 2002 yılları arasında tanı ko nulan akciğer dışı tüberkülo z o lgularının genel ö zellikleri1995 2002 yılları arasında tanı ko nulan akciğer dışı tüberkülo z o lgularının genel ö zellikleri ALATAŞ F., GÜLSÜM D., METİNTAŞ M., ERGİNEL M. S. , UÇGUN İ., AK G.

XXXIX. Çevresel asbest teması o lan bro nş kanserli o lguların epidemiyo lo jik ö zellikleriÇevresel asbest teması o lan bro nş kanserli o lguların epidemiyo lo jik ö zellikleri GÜRBÜZ B., METİNTAŞ S., METİNTAŞ M., UÇGUN İ., ALATAŞ F., ERGİNEL M. S.

Tüberküloz ve Toraks Dergisi, vol.52, no.1, pp.5-13, 2004 (Peer-Reviewed Journal)

XL. Malign Pato lo jisi Olmayan So lunum Yo ğun Bakım Hastalarında Mo rtalite Hızı ve Yüksek RiskliMalign Pato lo jisi Olmayan So lunum Yo ğun Bakım Hastalarında Mo rtalite Hızı ve Yüksek Riskli Hastanın Belirlenmesi

Hastanın Belirlenmesi

UÇGUN İ., METİNTAŞ M., MORAL H., ALATAŞ F., BEKTAŞ Y., YILDIRIM H., ERGİNEL M. S. , BAL C.

Toraks Dergisi, vol.4, no.2, pp.151-160, 2003 (Peer-Reviewed Journal) XLI. Astım ve Nazal Po lip25 Hastanın Retro spektif D eğerlendirilmesiAstım ve Nazal Po lip25 Hastanın Retro spektif D eğerlendirilmesi

YILDIRIM H., KURT E., METİNTAŞ M., ERGİNEL M. S. , ALATAŞ F., UÇGUN İ., ŞENER S.

Türkiye Klinikleri Allerji Astım Dergisi, no.5, pp.1-6, 2003 (Peer-Reviewed Journal) XLII. Tüberkülo z plö rezili o lguların genel ö zellikleriTüberkülo z plö rezili o lguların genel ö zellikleri

AK G., ALATAŞ F., METİNTAŞ M., METİNTAŞ S., UÇKUN N., ERGİNEL M. S. , KURT E.

Toraks Dergisi, 2002 (Peer-Reviewed Journal)

XLIII. Üniversiteye yeni başlayan ö ğrencilerde astım ve allerjik rinit prevalansı Üniversiteye yeni başlayan ö ğrencilerde astım ve allerjik rinit prevalansı D ö rt yıllık ko ho rt çalışmasıD ö rt yıllık ko ho rt çalışması ilk so nuçları

ilk so nuçları

ÖZDEMİR N., METİNTAŞ S., UÇGUN İ., MUSTAFA K., METİNTAŞ M., ERGİNEL M. S. , KURT E.

TÜBERKÜLOZ VE TORAKS, vol.49, no.3, pp.333-337, 2001 (Peer-Reviewed Journal) XLIV. Sko lyo zlu Sko lyo zlu yetişkinlerde yetişkinlerde kardiyo -pulmo ner kardiyo -pulmo ner fo nksiyo nların fo nksiyo nların değerlendirilmesideğerlendirilmesi

DEMİRTAŞ R. N. , ATA N., ÜNALIR A., TOPÇU A., YENERKOL B., METİNTAŞ M., ÖNER C.

Fizyoterapi Rehabilitasyon, vol.7, no.3, pp.21-28, 1993 (Peer-Reviewed Journal)

(13)

XLV. Üst abdo minal cerrahiden so nra pulmo ner fo nksiyo nlar üzerine gö ğüs fizyo terapisinin etkileri.Üst abdo minal cerrahiden so nra pulmo ner fo nksiyo nlar üzerine gö ğüs fizyo terapisinin etkileri.

DEMİRTAŞ R. N. , ÖNER C., KİPER M. H. , KARAHÜSEYİNOĞLU E., KURTARAN Y., BASIM H., METİNTAŞ M., KOÇ F.

Fizyoterapi Rehabilitasyon, vol.7, no.2, pp.29-37, 1992 (Peer-Reviewed Journal)

Books & Book Chapters Books & Book Chapters

I. Malign plevral mezo telyo ma'da tanı - invaziv tanıMalign plevral mezo telyo ma'da tanı - invaziv tanı Metintaş M.

in: Türkiye Klinikleri Göğüs Hastalıkları Mezotelyoma, Muzaffer Metintaş, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.1-85, 2020

II. Pulmo ner Hipertansiyo nPulmo ner Hipertansiyo n Metintaş M. (Editor)

in: Pulmoner Vasküler Hastalıklar, Elif Küpeli,Şerive Savaş Bozbaş,Muzaffer Metintaş, Editor, İstanbul Medikal Yayıncılık, İstanbul, pp.1-325, 2020

III. Kro nik Tro mbo embo lik Pulmo ner Hipertansiyo nKro nik Tro mbo embo lik Pulmo ner Hipertansiyo n Metintaş M.

in: Pulmoner Vasküler Hastalıklar, Elif Küpeli,Şerife Savaş Bozbaş,Muzaffer Metintaş, Editor, İstanbul Medikal Yayıncılık, İstanbul, pp.1-325, 2020

IV. GÖĞÜS HASTAL IKL ARI UZ MANL ARI İÇİNAKCİĞER KANSERİTED AVİ AL GORİTMAL ARI2019GÖĞÜS HASTAL IKL ARI UZ MANL ARI İÇİNAKCİĞER KANSERİTED AVİ AL GORİTMAL ARI2019

YILMAZ Ş., AK G., ÇELİK P., YILMAZ DEMİRCİ N., GÜLHAN M., kıyık m., kömürcüoğlu b. e. , METİNTAŞ M., ÖZTÜRK C., YILMAZ M. U. , et al.

www.solunum.org.tr, www.toraks.org.tr, www.asyod.org, 2019

V. Plevra, Plevral Aralığın Yapı ve İşlevi, Plevral Sıvılı Bir Hastanın D eğerlendirilmesi, Malign PlevralPlevra, Plevral Aralığın Yapı ve İşlevi, Plevral Sıvılı Bir Hastanın D eğerlendirilmesi, Malign Plevral Sıvılar

Sıvılar METİNTAŞ M.

in: Temel Akciğer Sağlığı ve Hastalıkları, Orhan Arseven, Editor, NOBEL TIP KİTABEVLERİ, İstanbul, pp.263-278, 2015

VI. Mezo telyo ma ve Türliye de asbest erio nite temasıMezo telyo ma ve Türliye de asbest erio nite teması METİNTAŞ M.

ROTA TIP, 2014

VII. Akciğer Kanseri Temel Akciğer Kanseri Temel BilgilerBilgiler METİNTAŞ M.

ROTA TIP, 2014

VIII. Şikayetten Tanıya Klinik D eğerlendirme Şikayetten Tanıya Klinik D eğerlendirme Akciğer Grafisi Akciğer Grafisi So lunum F o nksiyo n TestleriSo lunum F o nksiyo n Testleri METİNTAŞ M., Demircan F.

ROTA TIP, 2014

Refereed Congress / Symposium Publications in Proceedings Refereed Congress / Symposium Publications in Proceedings

I. PL EVRAL RAD YOTERAPİPL EVRAL RAD YOTERAPİ

ETİZ D., COŞKUN M., ÖZEN A., YILMAZ Ş., AK G., akmanlar m., karga ç., METİNTAŞ M.

UROK 2021, Antalya, Turkey, 26 November 2021

II. Malign plevral mezo telyo malı hastaların tedavi takibinde biyo belirteçlerin ro lü: Bo ylamsal analizMalign plevral mezo telyo malı hastaların tedavi takibinde biyo belirteçlerin ro lü: Bo ylamsal analiz BOĞAR F., AK G., METİNTAŞ S., AYHANCİ A., ÖZBAYER C., YILMAZ Ş., METİNTAŞ M.

Türkiye Solunum Araştırmaları Derneği 43. Ulusal Kongresi, 29 October 2021

III. 1990 – 2019 yılları arasında malign mezo telyo manın klinik ö zellikleri ve sağkalımı: Z aman seri1990 – 2019 yılları arasında malign mezo telyo manın klinik ö zellikleri ve sağkalımı: Z aman seri analizi

analizi

METİNTAŞ S., AK G., DÜNDAR E., METİNTAŞ M.

(14)

IV. İnterko stal damar zedelenmesinin ultraso no grafi ile tespitiİnterko stal damar zedelenmesinin ultraso no grafi ile tespiti KORUL F., KAVZOĞLU K., DURCEYLAN E., AK G., METİNTAŞ M.

V. Akciğer kanserli hastalarda grp78, grp94, kalretikülin ve kalneksin pro tein seviyelerinin sağkalımlaAkciğer kanserli hastalarda grp78, grp94, kalretikülin ve kalneksin pro tein seviyelerinin sağkalımla ilişkisi

ilişkisi

Ak G., Metintaş S., Turgut Coşan D., Kurt H., Yılmaz Ş., Metintaş M.

Türkiye Solunum Araştırmaları Derneği 43. Ulusal Kongresi, 29 October - 03 November 2021

VI. Malign plevral mezo telyo ma’da uzak metastaz: hemato jen ve lenfo jen yayım gö steren o lgu ö rnekleriMalign plevral mezo telyo ma’da uzak metastaz: hemato jen ve lenfo jen yayım gö steren o lgu ö rnekleri ÇELİK E., AYDIN N., DURMUŞ S., AK G., METİNTAŞ M.

VII. Plevra hastalıklarının tanısında invaziv yö ntemler: Hangi hastada hangi işlem?Plevra hastalıklarının tanısında invaziv yö ntemler: Hangi hastada hangi işlem?

METİNTAŞ M., AK G., YILDIRIM H., ALATAŞ F., ERGİNEL M. S. , DÜNDAR E., AYDIN N., YILMAZ Ş., METİNTAŞ S.

VIII. Machine L earning to Predict Survival in Small Cell L ung Cancer: A Pilo t StudyMachine L earning to Predict Survival in Small Cell L ung Cancer: A Pilo t Study YAKAR M. Ç. , ETİZ D., ÇELİK Ö., ÖZEN A., METİNTAŞ M., AK G., YILMAZ Ş., kütri d.

ESTRO 2021, Madrid, Spain, 31 August 2021

IX. Malignant Meso thelio ma Related to Enviro nmental Asbesto s Expo sure in a Rural Area: 30-yearMalignant Meso thelio ma Related to Enviro nmental Asbesto s Expo sure in a Rural Area: 30-year F o llo w-up

F o llo w-up

AK G., METİNTAŞ S., DÜNDAR E., METİNTAŞ M.

IASLC 2020 World Conference on Lung Cancer, 30 - 31 January 2021

X. The Co urse o f the Risk o f Meso thelio ma in Karain Co ho rt W ith Erio nite Expo sure L iving inThe Co urse o f the Risk o f Meso thelio ma in Karain Co ho rt W ith Erio nite Expo sure L iving in Sto ckho lm: No Erio nite Expo sure No Meso thelio ma

Sto ckho lm: No Erio nite Expo sure No Meso thelio ma Metintaş S., Metintaş M., Ak G., Hillerdal G.

IASLC 2020 World Conference on Lung Cancer, 28 - 31 January 2021, vol.16, pp.122

XI. The Ro le o f miRs in D etermining the Respo nse to Chemo therapy in MPM Patients Treated withThe Ro le o f miRs in D etermining the Respo nse to Chemo therapy in MPM Patients Treated with Chemo therapy

Chemo therapy

METİNTAŞ M., AK G., METİNTAŞ S., BOĞAR F., ÖZBAYER C.

IASLC 2020 World Conference on Lung Cancer, 29 - 30 January 2021

XII. The Co urse o f the Risk o f Meso thelio ma in Karain Co ho rt W ith Erio nite Expo sure L iving inThe Co urse o f the Risk o f Meso thelio ma in Karain Co ho rt W ith Erio nite Expo sure L iving in Sto ckho lm: No Erio nite Expo sure No Meso thelio ma.

Sto ckho lm: No Erio nite Expo sure No Meso thelio ma.

METİNTAŞ S., METİNTAŞ M., AK G., HILLERDAL G.

IASLC 2020 World Conference on Lung Cancer, 29 - 31 January 2021 XIII. Malign plevral mezo telyo manın pro gno z tayininde miRNA’ların ro lüMalign plevral mezo telyo manın pro gno z tayininde miRNA’ların ro lü

Metintaş M., Metintaş S., Ak G., Boğar F., Özbayer C.

Türkiye Solunum Araştırmaları Derneği 42. Ulusal Kongresi, 2 - 08 October 2020

XIV. Türkiye’nin Kapado kya Bö lgesi’nden Sto ckho lm’e gö ç edenlerde mezo telyo ma: Gen - çevre etkileşimiTürkiye’nin Kapado kya Bö lgesi’nden Sto ckho lm’e gö ç edenlerde mezo telyo ma: Gen - çevre etkileşimi METİNTAŞ S., METİNTAŞ M., AK G., Hillerdal G., Koyi H.

Türkiye Solunum Araştırmaları Derneği 42. Ulusal Kongresi, Turkey, 2 - 08 October 2020

XV. L OKAL İL ERİ EVRE AKCİĞER KANSERİND E MAKİNE ÖĞRENMESİ İL E RAD YASYON PNÖMONİSİL OKAL İL ERİ EVRE AKCİĞER KANSERİND E MAKİNE ÖĞRENMESİ İL E RAD YASYON PNÖMONİSİ TAHMİNL EME: PİL OT ÇAL IŞMA

TAHMİNL EME: PİL OT ÇAL IŞMA

Akçay M. Ç. , Yılmaz Ş., Etiz D., Çelik Ö., Ak G., Metintaş M.

14. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Antalya, Turkey, 26 - 30 November 2021

XVI. Evaluatio n o f gene mutatio n status and metastasis in lung adeno carcino ma: a multicentricEvaluatio n o f gene mutatio n status and metastasis in lung adeno carcino ma: a multicentric pro spective study in Turkey

pro spective study in Turkey

YILMAZ Ş., METİNTAŞ S., KARADAĞ M., YILMAZ DEMİRCİ N., AYDIN GÜÇLÜ Ö., AKIN KABALAK P., YILMAZ Ü., AK G., ÖZTÜRK A., YILMAZ M. U. , et al.

ERS 2019, 28 October - 02 November 2019

XVII. Ct-scan guided Abrams needle pleural bio psy o r medical thraco sco py: which metho d in whichCt-scan guided Abrams needle pleural bio psy o r medical thraco sco py: which metho d in which patient

patient

METİNTAŞ M., AK G., YILDIRIM H., YILMAZ Ş., DÜNDAR E., yüce t., METİNTAŞ S.

ERS International Congress, 28 September - 02 October 2019